Comment
doi: 10.1182/blood-2018-01-828145.
Consensus on MRD in AML?
Affiliations
- PMID: 29567752
- DOI: 10.1182/blood-2018-01-828145
Item in Clipboard
Comment
Consensus on MRD in AML?
Blood.
.
Free article
No abstract available
Conflict of interest statement
Conflict-of-interest disclosure: The author declares no competing financial interests.
Comment on
-
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party.Blood. 2018 Mar 22;131(12):1275-1291. doi: 10.1182/blood-2017-09-801498. Epub 2018 Jan 12. Blood. 2018. PMID: 29330221 Free PMC article. Review.
Similar articles
-
When it comes to MRD, AML ≠ ALL.Blood. 2012 Aug 23;120(8):1536-7. doi: 10.1182/blood-2012-06-435081. Blood. 2012. PMID: 22918419
-
High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: data from the HOVON/SAKK AML 42A study.J Clin Oncol. 2013 Nov 1;31(31):3889-97. doi: 10.1200/JCO.2012.45.9628. Epub 2013 Sep 23. J Clin Oncol. 2013. PMID: 24062400 Clinical Trial.
-
Minimal/Measurable Residual Disease Monitoring in NPM1-Mutated Acute Myeloid Leukemia: A Clinical Viewpoint and Perspectives.Int J Mol Sci. 2018 Nov 6;19(11):3492. doi: 10.3390/ijms19113492. Int J Mol Sci. 2018. PMID: 30404199 Free PMC article. Review.
-
High prognostic value of pre-allogeneic stem cell transplantation minimal residual disease detection by WT1 gene expression in AML transplanted in cytologic complete remission.Leuk Res. 2017 Dec;63:22-27. doi: 10.1016/j.leukres.2017.10.010. Epub 2017 Oct 27. Leuk Res. 2017. PMID: 29096332
-
Optimal Measurable Residual Disease Testing for Acute Myeloid Leukemia.Surg Pathol Clin. 2019 Sep;12(3):671-686. doi: 10.1016/j.path.2019.03.009. Epub 2019 May 18. Surg Pathol Clin. 2019. PMID: 31352980 Review.
Cited by
-
Clustering and Kernel Density Estimation for Assessment of Measurable Residual Disease by Flow Cytometry.Diagnostics (Basel). 2020 May 18;10(5):317. doi: 10.3390/diagnostics10050317. Diagnostics (Basel). 2020. PMID: 32443428 Free PMC article.
-
Dendritic Cells of Leukemic Origin: Specialized Antigen-Presenting Cells as Potential Treatment Tools for Patients with Myeloid Leukemia.Transfus Med Hemother. 2020 Dec;47(6):432-443. doi: 10.1159/000512452. Epub 2020 Nov 5. Transfus Med Hemother. 2020. PMID: 33442338 Free PMC article. Review.
-
Measurable Residual Disease in Acute Myeloid Leukemia Using Flow Cytometry: A Review of Where We Are and Where We Are Going.J Clin Med. 2020 Jun 3;9(6):1714. doi: 10.3390/jcm9061714. J Clin Med. 2020. PMID: 32503122 Free PMC article. Review.
-
Minimal Residual Disease in Acute Myeloid Leukemia: Old and New Concepts.Int J Mol Sci. 2024 Feb 10;25(4):2150. doi: 10.3390/ijms25042150. Int J Mol Sci. 2024. PMID: 38396825 Free PMC article. Review.
-
When to obtain genomic data in acute myeloid leukemia (AML) and which mutations matter.Blood Adv. 2018 Nov 13;2(21):3070-3080. doi: 10.1182/bloodadvances.2018020206. Blood Adv. 2018. PMID: 30425072 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
